发明授权
US08431125B2 Methods of treating lupus nephritis using antibodies against monocyte chemotactic proteins
有权
使用针对单核细胞趋化蛋白的抗体治疗狼疮肾炎的方法
- 专利标题: Methods of treating lupus nephritis using antibodies against monocyte chemotactic proteins
- 专利标题(中): 使用针对单核细胞趋化蛋白的抗体治疗狼疮肾炎的方法
-
申请号: US13156959申请日: 2011-06-09
-
公开(公告)号: US08431125B2公开(公告)日: 2013-04-30
- 发明人: Antonin R. De Fougerolles , Victor E. Kotelianski , Carl Reid , Ellen Garber
- 申请人: Antonin R. De Fougerolles , Victor E. Kotelianski , Carl Reid , Ellen Garber
- 申请人地址: US MA Cambridge
- 专利权人: Biogen Idec MA, Inc.
- 当前专利权人: Biogen Idec MA, Inc.
- 当前专利权人地址: US MA Cambridge
- 代理机构: Finnegan, Henderson, Farabow, Garret & Dunner
- 主分类号: A61K39/395
- IPC分类号: A61K39/395
摘要:
The invention provides antibodies that bind to a plurality of β-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.
公开/授权文献
- US20120039873A1 ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS 公开/授权日:2012-02-16